Xilio Therapeutics, Inc.XLONASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P100
Near historical high
vs 2Y Ago
11.8x
Strong expansion
Streak
3 yr
Consecutive growthAccelerating
PeriodValue
202473.22%
20239.38%
20226.23%
2021-123.74%
2020-102.27%
20190.00%